RankingsPricing
  1. US-listed companies
  2. CONMED Corp
  3. Financials
  4. Stock-based compensation

CONMED CorpCNMD

Market cap
$1.3B
P/E ratio
SummaryFinancials
Period EndStock-based compensation (Million USD)YoY (%)
Dec 31, 202426+5.18%
Dec 31, 202324+11.98%
Dec 31, 202222+33.13%
Dec 31, 202116+24.43%
Dec 31, 202013+11.02%
Dec 31, 201912+17.57%
Dec 31, 201810+18.47%
Dec 31, 20178+1.16%
Dec 31, 20168+11.68%
Dec 31, 20157-19.62%
Dec 31, 20149+66.82%
Dec 31, 20136-1.06%
Dec 31, 20126+7.88%
Dec 31, 20115

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)